Servier Polska sp. z o.o.

Business and other management consultancy activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-11-15
Share capital
20,944,250.00 PLN
Activity description

Servier Polska is a pharmaceutical company that focuses on three therapeutic areas: cardiometabolism, oncology, and neurology. It has developed worasydenib, a targeted molecular therapy for patients with grade 2 glioma with IDH gene mutations. The company employs 20,000 people and treats 100 million patients daily with its original medications.

Registered address
ul. Burakowska 14, 01-066 Warszawa, Poland
Website
Opening hours
Mon–Fri, 8:30–17:30
Email
Phone
Social media
Electronic delivery address
AE:PL-40852-81184-VHSHG-17

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 40 days early. All were audited by a statutory auditor.

  • 202525/03/2026
  • 202414/04/2025
  • 202310/04/2024
  • 202213/04/2023
  • 202112/04/2022
  • 202021/12/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

City · Warszawa1,263 / 56,772
Top 2.2%
Voivodeship · Mazowieckie1,669 / 76,953
Top 2.2%
Country · Poland5,166 / 297,266
Top 1.7%

Results vs industry

Revenue
This companyUSD 44.42mMedianUSD 80.78kAverageUSD 1.92m
Net profit
This companyUSD 1.26mMedianUSD 3.50kAverageUSD 117.89k
Operating costs
This companyUSD 41.91mMedianUSD 58.86kAverageUSD 1.65m
Assets
This companyUSD 22.91mMedianUSD 65.78kAverageUSD 2.86m

Industry

Offer

Websites

The company has 9 websites. Most of them run on WordPress. The sites are available in: Polish, English, German, Ukrainian, French and 8 more. The sites target these markets: United States, Ukraine, Switzerland, United Arab Emirates, Belgium and 15 more. Traffic on the sites is measured with Google Analytics.

  • servier.plStrona główna – Servier Polska
    WordPress 6.7Yoast SEOApache
  • akademiaservier.plAkademia Servier
    WordPress 7.1Google AnalyticsGoogle Tag ManagerApache
  • dbajoserce.plDbaj o serce - kampania społeczna
    WordPress 7.1Google AnalyticsGoogle Tag ManagerApache

Public procurement

9 tenders recorded as contractor: 2 national ($62,440) and 7 EU ($5,274).

SubjectAmount
Supply of medicines for SP ZZOZ in Przasnysz
$184
Supply of medicinal products and medical devices, specialist dressings, items recently added to the formulary and medicines used in drug programmes – supplementary order
$551
Supply of medicinal products for SP ZOZ in Łęczna
$2,505

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2002.

MarkNumberClassesStatusProtected until
MediBase Z.2550449, 16, 35, 41, 42Expired –
MarkProtected until
MediBase –

Job offers

The company has its own careers page: servier.pl/dolacz-do-nas.

Authorized Representatives

Joanna Małgorzata Drewla age 60 – Management Board Member
Philippe Louis Malet – Management Board Member

Manner of representation

Each member of the management board has the right to represent the company individually.

Ownership

OwnerShare valueStake
Biofarma S.a.s.
$5,657,549.97100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1998-04-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Janssen-Cilag Polska sp. z o.o.
Takeda Pharma sp. z o.o.
Chiesi Poland sp. z o.o.
Synoptis Pharma sp. z o.o.
Polfarmex S.A.
Solinea sp. z o.o.
Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. Branch (foreign co.)
SUN-Farm sp. z o.o.
Tactica Pharmaceuticals sp. z o.o.
Glenmark Pharmaceuticals sp. z o.o.

Change history

DateEvent
2025-07-16Switch to PKD 2025
2022-11-21Address change
2017-05-30PKD change
2010-09-17Switch to PKD 2007
2005-07-20Address change

FAQ

Last updated: 2026-10-07